Medison to tough it out

Article

Since being forced into court receivership March 8, Korean ultrasound developer Medison had been seeking a white knight. But no more. The company best known for its pioneering efforts in 4D ultrasound has decided to stop looking for a corporate savior

Since being forced into court receivership March 8, Korean ultrasound developer Medison had been seeking a white knight. But no more. The company best known for its pioneering efforts in 4D ultrasound has decided to stop looking for a corporate savior and make it on its own. The company had attracted several suitors, including a number of foreign and domestic firms and a consortium. In each case, however, the proposed terms were too severe for Medison executives to accept, according to the company. In the meantime, the firm has divested itself of activities outside medical ultrasound and has posted strong sales revenue during this year's first half, leading to optimism that the company can succeed by itself.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.